In a post to its corporate LinkedIn page, Veeva (VEEV) offered congratulations to GSK‘s (GSK) SVP of global medical affairs and technology, Kieron Scrutton, on the successful Vault CRM go-live across Europe.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Options Volatility and Implied Earnings Moves This Week, August 25 – August 29, 2025
- VEEV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cautious Outlook on Veeva Systems Amid Growth Sustainability Concerns and Sector Risks
- Veeva Systems: Hold Rating Amid High Expectations and Macroeconomic Concerns
- Veeva price target raised to $268 from $230 at Truist